Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ceftobiprole – Injectable Anti-MRSA Cephalosporin Antibiotic

Ceftobiprole medocaril (BAL5788) is the product of a joint development programme between Basilea Pharmaceutica AG and Cilag AG International (a Johnson & Johnson company).



  • Ceftobiprole medocaril
  • Basilea Pharmaceutica
  • Ceftobiprole Medocaril
  • Infections in hospitalised patients
  • Ceftobiprole has been approved

Go Top